Myomo (MYO) Change in Receivables (2016 - 2025)
Myomo's (MYO) quarterly Change in Receivables came in at -$1.9 million in Q3 2025, down 283.81% YoY from $1.0 million in Q3 2024, and down 179.72% on a QoQ basis from $2.3 million in Q2 2025.
Myomo (MYO) Change in Receivables (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Change in Receivables data on file, last reported at -$1.9 million in Q3 2025.
- Quarterly Change in Receivables fell 283.81% year-over-year to -$1.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.6 million (up 57.6% YoY) and the FY2024 annual result came in at $1.6 million, up 214.69% from the prior year.
- Change in Receivables eased to -$1.9 million in Q3 2025, from $2.3 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.3 million in Q2 2025 to a low of -$1.9 million in Q3 2025.
- A 5-year average of $219224.1 and a median of $239274.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2021 — Change in Receivables surged 6143.87% — and 2025, when it tumbled 283.81%.
- Tracing MYO's Change in Receivables over 5 years: stood at -$235707.0 in 2021, then jumped by 233.77% to $315314.0 in 2022, then sank by 141.23% to -$129997.0 in 2023, then soared by 440.97% to $443252.0 in 2024, then tumbled by 520.54% to -$1.9 million in 2025.
- The last three Change in Receivables figures came in at -$1.9 million (Q3 2025), $2.3 million (Q2 2025), and $637054.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Myomo | 71.05 Mn | 52.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Mar 31, 2025 | 637,054.00 |
| Mar 31, 2025 | 637,054.00 |
| Dec 31, 2024 | 443,252.00 |
| Dec 31, 2024 | 443,252.00 |
| Sep 30, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 820,910.00 |
| Jun 30, 2024 | 820,910.00 |
| Mar 31, 2024 | -718,676.00 |
| Mar 31, 2024 | -718,676.00 |
| Dec 31, 2023 | -129,997.00 |
| Dec 31, 2023 | -129,997.00 |
| Sep 30, 2023 | 861,473.00 |
| Sep 30, 2023 | 861,473.00 |
| Jun 30, 2023 | 104,656.00 |
| Jun 30, 2023 | 104,656.00 |